Page last updated: 2024-08-22

Brilliant Blue and Seizures

Brilliant Blue has been researched along with Seizures in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nieoczym, D; Socała, K; Wlaź, P	1

Other Studies

1 other study(ies) available for Brilliant Blue and Seizures

Article	Year
Evaluation of the Anticonvulsant Effect of Brilliant Blue G, a Selective P2X7 Receptor Antagonist, in the iv PTZ-, Maximal Electroshock-, and 6 Hz-Induced Seizure Tests in Mice. Neurochemical research, 2017, Volume: 42, Issue:11 Topics: Animals; Anticonvulsants; Benzenesulfonates; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Infusions, Intravenous; Male; Mice; Pentylenetetrazole; Purinergic P2X Receptor Antagonists; Seizures; Treatment Outcome	2017

Article

Year

Evaluation of the Anticonvulsant Effect of Brilliant Blue G, a Selective P2X7 Receptor Antagonist, in the iv PTZ-, Maximal Electroshock-, and 6 Hz-Induced Seizure Tests in Mice.

Neurochemical research, 2017, Volume: 42, Issue:11

Topics: Animals; Anticonvulsants; Benzenesulfonates; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Infusions, Intravenous; Male; Mice; Pentylenetetrazole; Purinergic P2X Receptor Antagonists; Seizures; Treatment Outcome

2017